RUTHERFORD, N.J., April 3, 2014 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), an emerging leader in DNA-based diagnostics, announced today that a poster highlighting preliminary results of a study in clear cell Renal Cell Carcinoma (ccRCC) will be presented at the 105th Annual Meeting of the American Association of Cancer Research (“AACR”), which will be held in San Diego, California April 5-9, 2014.
Help employers find you! Check out all the jobs and post your resume.
